Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
03/28/2001 | EP1087017A2 The cytoplasmic inhibition of gene expression |
03/28/2001 | EP1087014A1 Hog cholera virus vaccine and diagnostic |
03/28/2001 | EP1087013A2 Immunoglobulins devoid of light chains |
03/28/2001 | EP1087012A1 Groups of genes expressed in human dendritic cells |
03/28/2001 | EP1087011A2 Methods for preventing degradation of protein c |
03/28/2001 | EP1086955A1 Peptides against antibodies elicited by DCM |
03/28/2001 | EP1086954A1 Peptides against autoantibodies elicited by DCM |
03/28/2001 | EP1086742A1 Combinatorial strategies for polymer synthesis |
03/28/2001 | EP1086704A1 Eosinophil chemotactic factor |
03/28/2001 | EP1086377A1 A method of identifying ligands to rna polymerase sigma 70 subunit |
03/28/2001 | EP1086252A1 Herpes simplex virus origin binding protein n-terminal truncation (obp-nt) |
03/28/2001 | EP1086246A1 Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer |
03/28/2001 | EP1086234A1 New human carboxypeptidase inhibitor |
03/28/2001 | EP1086232A1 A vaccine-induced hepatitis b viral strain and uses thereof |
03/28/2001 | EP1086231A2 ENHANCEMENT OF B CELL ACTIVATION AND IMMUNOGLOBULIN SECRETION BY CO-STIMULATION OF RECEPTORS FOR ANTIGEN AND EBV Gp350/220 |
03/28/2001 | EP1086230A1 Bactericidal/permeability-increasing protein (bpi) deletion analogs |
03/28/2001 | EP1086229A2 Moraxella catarrhalis polynucleotides and polypeptides |
03/28/2001 | EP1086228A1 Recombinant production of toxoplasma sag1 antigen |
03/28/2001 | EP1086227A1 Novel maize orthologues of bacterial reca proteins |
03/28/2001 | EP1086226A1 Cyclin-dependent kinase inhibitors as plant growth regulators |
03/28/2001 | EP1086225A2 Human tumour-derived polypeptide hormone phosphatonin |
03/28/2001 | EP1086224A1 B2 microglobulin fusion proteins and high affinity variants |
03/28/2001 | EP1086223A2 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
03/28/2001 | EP1086222A2 Cell cycle regulation proteins |
03/28/2001 | EP1086221A2 Truncated apaf-1 and methods of use thereof |
03/28/2001 | EP1086220A2 Dna coding for gdnf, parts of said dna and gdnf variants |
03/28/2001 | EP1086219A2 Proteins regulating gene expression |
03/28/2001 | EP1086218A2 Genes and gene expression products that are differentially regulated in prostate cancer |
03/28/2001 | EP1086217A2 Novel angiotensin receptor, production and use thereof |
03/28/2001 | EP1086215A2 Preparation and use of superior vaccines |
03/28/2001 | EP1086213A2 Human genes differentially expressed in colon cancer |
03/28/2001 | EP1086207A1 Novel methods and interferon deficient substrates for the propagation of viruses |
03/28/2001 | EP1086138A2 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
03/28/2001 | EP1086135A2 "monoclonal anitbody and assay for detecting n-terminal procollagen (iii) propeptide (piiinp)" |
03/28/2001 | EP1086133A1 A method for the removal/purification of serum albumins and means for use in the method |
03/28/2001 | EP1086132A1 Gene encoding organic anion transporter |
03/28/2001 | EP1086131A1 Cyclic somatostatin analogs |
03/28/2001 | EP1086130A1 Insulin analogue |
03/28/2001 | EP1086129A1 Anti-angiogenic proteins and methods of use thereof |
03/28/2001 | EP1086128A2 Plant protein with repeated wd40 motifs, nucleic acid coding for said protein, and uses thereof |
03/28/2001 | EP1086127A1 Novel compounds |
03/28/2001 | EP1086126A1 Cell-permeable peptide |
03/28/2001 | EP1086125A1 Respiratory nitrate reductase alpha subunit |
03/28/2001 | EP1086121A1 Non-enzymatic chemical amidation process |
03/28/2001 | EP1086120A1 Method for preparing virus-safe pharmaceutical compositions |
03/28/2001 | EP1086117A1 Cloning and identification of the motilin receptor |
03/28/2001 | EP1085909A2 Composition for the treatement of immune deficiencies and methods for its preparation and use |
03/28/2001 | EP1085904A1 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
03/28/2001 | EP1085903A1 Egg surface proteins and methods for use for modulating fertility |
03/28/2001 | EP1085899A1 Retinoic acid inducible dna sequences from lung cells |
03/28/2001 | EP1085898A1 Parasite antigens |
03/28/2001 | EP1085897A1 Acrp30r1l, a homolog of acrp30 (30 kd adipocyte complement-related protein) |
03/28/2001 | EP1085896A1 Conformationally constrained backbone cyclized somatostatin analogs |
03/28/2001 | EP1085882A2 Use of genetically engineered antibodies to cd38 to treat multiple myeloma |
03/28/2001 | EP0779815B1 Surface-modifying copolymers having cell adhesion properties |
03/28/2001 | EP0495096B1 Plant fatty acid synthases |
03/28/2001 | EP0221173B1 Diagnostic reagents based on unique sequences within the variable region of the t cell receptor and uses thereof |
03/28/2001 | CN1289373A Inhibition of DNA modulation caused by mutated p53 |
03/28/2001 | CN1289366A Human TSC403 gene and human INGIL gene |
03/28/2001 | CN1289339A Genetic immunization with nonstructural proteins of hepatitis c virus |
03/28/2001 | CN1289252A Treatment of follicular lymphomas using inhibitors of the lymphotoxin (LT) pathway |
03/28/2001 | CN1288897A Preparation of human vasal endothelial cell growth inhibitor and its application in tumor angiogenesis resisting treatment |
03/28/2001 | CN1063796C Preparation method for drythropoietin isoforms |
03/28/2001 | CN1063795C Method for production of glucagon |
03/28/2001 | CN1063757C Gene structure with calcitonin gene related peptide (CGRP) and preparing method thereof |
03/28/2001 | CN1063756C Double antigen containing hepatitis B virus and hepatitis C virus core antigen simultaneously |
03/27/2001 | US6207883 DNA sequences coding for a protein conferring male sterility |
03/27/2001 | US6207880 Plants which synthesize a modified starch, process for the production thereof and modified starch |
03/27/2001 | US6207817 Fish insulin-like growth factor II promoter |
03/27/2001 | US6207816 High affinity oligonucleotide ligands to growth factors |
03/27/2001 | US6207814 Activin receptor-like kinases, ALK-3 and ALK-6, and nucleic acids encoding them |
03/27/2001 | US6207813 BMP-6 proteins |
03/27/2001 | US6207812 Chondrosarcoma associated genes |
03/27/2001 | US6207811 Nephrin gene and protein |
03/27/2001 | US6207807 Immobilizing a peptide which binds to fc region of antibody onto an affinity chromatography support, packing into column, equilibrating with buffer, applying solution to column, washing with eluent to remove impurites, eluting antibodies |
03/27/2001 | US6207806 IGF-I purification process |
03/27/2001 | US6207805 Hybridoma which secretes monoclonal antibodies; diagnosis; anticarcinogenic agents with reduced side effects; imaging |
03/27/2001 | US6207804 Genetically engineered antibody analogues and fusion proteins thereof |
03/27/2001 | US6207803 Amino acid sequence of polypeptide; anticarcinogenic agents; antitumor agents; treatment of automimmune disorders, blood disorders; alzheimer's/parkinson's disease, septic shock, osteoporosis, polycystic kidney disease; viricides; diagnosis |
03/27/2001 | US6207802 Non-human, mammalian polypeptide of defined amino acid sequence which activates the growth of early hematopoietic progenitor cells; treatment of blood disorders; anticarcinogenic agents; bone marrow regeneration |
03/27/2001 | US6207801 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same |
03/27/2001 | US6207799 Neuropeptide Y receptor Y5 and nucleic acid sequences |
03/27/2001 | US6207798 Includes psuedomonas exotoxin-40 domain modified by replacement of at least two cysteines with alanines and a cell growth factor or hormone domain; targeted anticarcinogenic agents |
03/27/2001 | US6207703 Mucoadministering to airways formulation comprising antifungal agent to reduce or eliminate symptoms of asthma |
03/27/2001 | US6207646 Immunostimulatory nucleic acid molecules |
03/27/2001 | US6207645 Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations |
03/27/2001 | US6207642 Member of the TNF family useful for treatment and diagnosis of disease |
03/27/2001 | US6207641 Pharmaceutical composition containing IFN-γ inducing polypeptide or factor for treating and/or preventing IFN-γ susceptive diseases |
03/27/2001 | US6207640 Treatment of partial growth hormone insensitivity syndrome |
03/27/2001 | US6207639 Contacting a neuron with a cell adhesion modulating peptide that comprises a cyclic peptide in which nonadjacent amino acid residues are covalently linked to form a peptide ring comprising sequence his-ala-val within cyclic peptide ring |
03/27/2001 | US6207457 Targeted nucleotide sequence delivery and integration system |
03/27/2001 | US6207455 Lentiviral vectors |
03/27/2001 | US6207454 Exposing target mammalian cell that expresses stem cell factor receptor to active stem cell factor or analog, then introducing polynucleotide to cell; gene therapy |
03/27/2001 | US6207453 A replication-defective adeno-associated virus vector containing exogenous dna bound to a dna which codes for a rep protein; gene therapy |
03/27/2001 | US6207452 Antibody of the anti-proliferation domain of human Bcl-2 |
03/27/2001 | US6207450 Nucleic acid of defined nucleotide sequence which encodes fkhl7 protein; drug screening; primers; probes; gene therapy; antibodies; recombinant production |
03/27/2001 | US6207449 Nucleotide sequence of gene; hybridization probes for detection; drug screening for bactericides, bacteriostats and antibiotics |
03/27/2001 | US6207446 Selection of proteins using RNA-protein fusions |
03/27/2001 | US6207442 Plasmid construction by homologous recombination |
03/27/2001 | US6207440 Bacterial strain includes defined nucleotide sequence; fish aquariums; aquaculture |